TGTX
Tg Therapeutics, Inc.Company with tickers: TGTX
CIK
1001316
CUSIP
88322Q108
Shares Outstanding
153,083,580
Website
https://www.tgtherapeutics.com
Investor Relations
https://www.tgtherapeutics.com/investors-media/
13F Activity (30d)
131 filings
112 filers
Price
$49.52
Market Cap
$7.58B
P/E Ratio
17.88
EPS (Diluted)
$2.77
52W High
$50.41
52W Low
$25.28
Daily open, high, low and close prices with derived technical indicators (moving averages, RSI and more). Price data syncs automatically from Yahoo Finance.
Latest guidance
from the 8-K filed May 6, 2026
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
| total global revenue | full year 2026 | $925M | — | — |
| BRIUMVI U.S. net product revenue | second quarter 2026 | $220M | — | — |
5 Up Days
Price, Moving Averages & Bollinger Bands
RSI (14)
MACD (12, 26, 9)
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TGTX | +23.3% | +21.4% | +65.5% | +30.5% | +66.1% |
| SPY | +0.6% | -0.9% | +9.7% | -2.0% | +8.8% |
| vs SPY | +22.7% | +22.3% | +55.8% | +32.5% | +57.4% |
Close
$49.52
Open
$48.05
52W High
$50.41
52W Low
$25.28
Avg Vol (30d)
2.0M
Data Range
2020-01-02 — 2026-06-12